Effects of annual influenza vaccination on morbidity and mortality in patients with Systemic Lupus Erythematosus: A Nationwide Cohort Study

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Chang, Chi Ching ^a,b   Chang, Yu Sheng ^c   Chen, Wei Sheng ^d   Chen, Yi Hsuan ^e   Chen, Jin Hua ^e  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; COMPLICATION; DIALYSIS; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; INFLUENZA; INFORMATION PROCESSING; INTENSIVE CARE UNIT; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; REGISTER; RETROSPECTIVE STUDY; RISK; SYSTEMIC LUPUS ERYTHEMATOSUS; TAIWAN; VACCINATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DATA COLLECTION; DIALYSIS; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTENSIVE CARE UNITS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK; TAIWAN; VACCINATION; YOUNG ADULT;

EID: 85000416093     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep37817     Document Type: Article

References (38)

1. Bouza, E., Moya, G. L. & Munoz, P. Infections in systemic lupus erythematosus and rheumatoid arthritis. Infect Dis Clin N Am. 15, 335-361 (2001).
2. Alarcón, G. S. Infections in Systemic connective tissue diseases: systemic lupus erythematosus, scleroderma, and polymyositis/dermatomyositis. Infect Dis Clin N Am. 20, 849-875 (2006).
3. Fessler, B. J. Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis. Best Pract Res Clin Rheumatol. 16, 281-291 (2002).
4. Nicholson, K. G., Wood, J. M. & Zambon, M. Influenza. Lancet. 362, 1733-1745 (2003).
5. Thompson, W. W. et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 289, 179-186 (2003).
6. Thompson, W. W. et al. Influenza-associated hospitalizations in the United States. JAMA. 292, 1333-1340 (2004).
7. Fiore, A. E. et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 59, 1-62 (2010).
8. Hayden, F. G. Prevention and treatment of influenza in immunocompromised patients. Am J Med. 102, 55-60 (1997).
9. Conti, F., Rezai, S. & Valesini, G. Vaccination and autoimmune rheumatic diseases. Autoimmun Rev. 8, 124-128 (2008).
10. Holvast, B., Huckriede, A., Kallenberg, C. G. & Bijl, M. Influenza vaccination in systemic lupus erythematosus: safe and protective? Autoimmun Rev. 6, 300-305 (2007).
11. Kallenberg, C. G., Limburg, P. C., Van Slochteren, C. & Van der Woude, F. J. B cell activity in systemic lupus erythematosus: depressed in vivo humoral immune response to a primary antigen (haemocyanin) and increased in vitro spontaneous immunoglobulin synthesis. Clin Exp Immunol. 53, 371-383 (1983).
12. Herron, A. et al. Influenza vaccination in patients with rheumatic diseases. Safety and efficacy. JAMA. 242, 53-56 (1979).
13. Louie, J. S. et al. Clinical and antibody responses after influenza immunization in SLE. Ann Int Med. 88, 790-792 (1978).
14. Williams, G. W., Steinberg, A. D. & Reinsen, L. Influenza immunization in SLE. A double blind trial. Ann Int Med. 88, 729-734 (1978).
15. Broadman, R., Gilfillan, R. & Glass, D. Influenza vaccine response in SLE. Ann Int Med. 88, 735-740 (1978).
16. Ristow, S. C., Douglas, R. G. & Condemi, J. J. Influenza vaccination of patients with SLE. Ann Int Med. 88, 786-9 (1978).
17. Hess, E. V. & Hann, H. B. Influenza immunization in lupus erythematosus: safe effective? Ann Int Med. 88, 833-834 (1978).
18. Battafarano, D. F. et al. Antigen-specific antibody responses in lupus patients following immunization. Arthritis Rheum. 10, 1828-834 (1998).
19. Abu-Shakra, M. et al. Influenza virus vaccination of patients with systemic lupus erythematosus: effects on disease activity. J Rheumatol. 27, 1681-1685 (2000).
20. Abu-Shakra, M. et al. Specific antibody response after influenza immunization in systemic lupus erythematosus. J Rheumatol. 29, 2555-2557 (2002).
21. Kanakoudi-Tsakalidou, F., Trachana, M., Pratsidou-Gertsi, P., Tsitsami, E. & Kyriazopoulou-Dalaina, V. Influenza vaccination in children with chronic rheumatic diseases and long-term immunosuppressive therapy. Clin Exp Rheumatol. 19, 589-594 (2001).
22. Fiore, A. E. et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 48, 1-28 (1999).
23. Abu-Shakra, M., Press, J., Buskila, D. & Sukenik, S. Influenza vaccination of patients with systemic lupus erythematosus: safety and immunogenecity issues. Autoimmun Rev. 6, 543-546 (2007).
24. Gluck, T. & Muller-Ladner, U. Vaccination in patients with chronic rheumatic or autoimmune diseases. Clin Infect Dis. 46, 1459-1465 (2008).
25. Mosca, M. et al. EULAR recommendations for monitoring systemic lupus erythematosus patients in clinical practice and in observational studies. Ann Rheum Dis. 69, 1269-1274 (2010).
26. Yazdany, J. et al. A quality indicator set for systemic lupus erythematosus. Arthritis Rheum. 61, 370-377 (2009).
27. Ristow, S. C., Douglas, R. G. & Condemi, J. J. Influenza vaccination of patients with systemic lupus erythematosus. Ann Intern Med. 88, 786-789 (1978).
28. Duchini, A., Hendry, R. M., Nyberg, L. M., Viernes, M. E. & Pockros, P. J. Immune response to influenza vaccine in adult liver transplant recipients. Liver Transpl. 7, 311-313 (2001).
29. Mazzone, P. J. et al. The humoral immune response to influenza vaccination in lung transplant patients. Eur Respir J. 18, 971-6 (2001).
30. Soesman, N. M. et al. Efficacy of influenza vaccination in adult liver transplant recipients. J Med Virol. 61, 85-93 (2000).
31. Nichol, K. L. & Zimmerman, R. Generalist and subspecialist physicians' knowledge, attitudes, and practices regarding influenza and pneumococcal vaccinations for elderly and other high-risk patients. Arch Intern Med. 161, 2702-2708 (2001).
32. Brull, R., Ghali, W. A. & Quan, H. Missed opportunities for prevention in general internal medicine. CMAJ. 160, 1137-1140 (1999).
33. Cabana, M. D. et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 282, 1458-1465 (1999).
34. Fedson, D. S. Adult immunization. Summary of the National Vaccine Advisory Committee Report. JAMA. 272, 1133-1137 (1994).
35. Stojanovich, L. Influenz vaccination of patients with systemic lupus erythematosus and rheumatoid arthritis. Clin Dev Immunol. 13, 373-5 (2006).
36. Liao, Z. et al. Immunogenicity and Safety of Influenza Vaccination in Systemic Lupus Erythematosus Patients Compared with Healthy Controls: A Meta-Analysis. PLoS One. 11, 1-13 (2016).
37. Murdaca, G. et al. Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: current views upon safety and immunogenicity. Autoimmun Rev. 13, 75-84 (2014).
38. Wiesik, S. E., Lacki, J. K. & Chwalińiska, S. H. Should we vaccinate patients with systemic lupus. Pol Merkur Lekarski. 23, 395-8 (2007).